![George Lloyd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Lloyd
Chief Investment Officer bij
RP Management LLC
Vermogen: 573 M $ op 31-05-2026
Profiel
Momenteel bekleedt George Lloyd de functie van Executive VP-Investments & General Counsel bij RP Management LLC en Executive VP-Investments & General Counsel bij Royalty Pharma Plc. Hij is ook lid van de raad van bestuur van Royalty Pharma Holdings Ltd. In het verleden was hij Partner bij Goodwin Procter LLP, Associate bij Davis Polk & Wardwell LLP en Partner bij Testa, Hurwitz & Thibeault LLP. Hij is afgestudeerd aan de Princeton University en heeft een graad in de rechten behaald aan de New York Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RPI US Partners 2019 LP
 RPI US Partners 2019 LP Financial ConglomeratesFinance Functions as an investment fund 3,53% | 08-08-2025 | 7.527.320 ( 3,53% ) | 420 M $ | 31-05-2026 |
ROYALTY PHARMA PLC 7,93% | 16-05-2025 | 1.944.471 ( 7,93% ) | 108 M $ | 31-05-2026 |
| 18-12-2025 | 779.915 ( 0,18% ) | 43 M $ | 31-05-2026 | |
RPI International Holdings 2019 LP
 RPI International Holdings 2019 LP Financial ConglomeratesFinance Functions as an investment fund 0,07% | 18-06-2020 | 20.500 ( 0,07% ) | 1 M $ | 31-05-2026 |
Actieve functies van George Lloyd
| Bedrijven | Functie | Begin |
|---|---|---|
RP Management LLC
 RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Chief Investment Officer | 18-05-2011 |
Royalty Pharma Holdings Ltd.
 Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Bestuurslid | 10-06-2020 |
Eerdere bekende functies van George Lloyd
| Bedrijven | Functie | Einde |
|---|---|---|
| ROYALTY PHARMA PLC | Chief Investment Officer | 31-12-2025 |
Davis Polk & Wardwell LLP
 Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Testa, Hurwitz & Thibeault LLP
 Testa, Hurwitz & Thibeault LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
Opleiding van George Lloyd
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Davis Polk & Wardwell LLP
Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Testa, Hurwitz & Thibeault LLP
Testa, Hurwitz & Thibeault LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RP Management LLC
RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Finance |
New York Law School
 New York Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Royalty Pharma Holdings Ltd.
Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
